Table 7.

Components of the primary end point reached in the JUPITER study

End point	Rosuvastatin group	Placebo group	Hazard ratio	95% CI	P value
Primary end point	142	251	0.56	0.46–0.69	<0.00001
Nonfatal MI	22	62	0.35	0.22–0.58	<0.00001
Any MI	31	68	0.46	0.30–0.70	<0.0002
Nonfatal stroke	30	58	0.52	0.33–0.80	0.003
Any stroke	33	64	0.52	0.34–0.79	0.002
Revascularization or Unstable angina	76	143	0.53	0.40–0.70	<0.00001
MI, stroke, CV death	83	157	0.53	0.40–0.69	<0.00001
Total mortality	198	247	0.80	0.67–0.97	0.02
CV death (verified)	35	43	0.82	0.52–1.27	0.37
Sudden death	16	25	0.64	0.34–1.20	0.16

Abbreviations: CI, confidence interval; CV, cardiovascular; MI, myocardial infarction.